Loading the security overview…
Where the tokens are
Trade LRCX
Trade LRCX perps| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q4 FY26ended Jun 28, 2026 | Jul 29, 2026 | $1.81 | +34.1% | $6.72B | +30.0% | $1.69 |
| Q3 FY26ended Mar 29, 2026 | Apr 29, 2026 | $1.45 | +40.8% | $5.84B | +23.8% | $1.35 |
| Q2 FY26ended Dec 28, 2025 | — | $1.26 | +37.0% | $5.34B | +22.1% | — |
| Q1 FY26ended Sep 28, 2025 | — | $1.24 | +44.2% | $5.32B | +27.7% | — |
| Q4 FY25ended Jun 29, 2025 | — | $1.35 | +73.1% | $5.17B | +33.6% | — |
| Q3 FY25ended Mar 30, 2025 | — | $1.03 | +41.1% | $4.72B | +24.4% | — |
| Q2 FY25ended Dec 29, 2024 | — | $0.92 | +27.8% | $4.38B | +16.4% | — |
| Q1 FY25ended Sep 29, 2024 | — | $0.86 | +28.4% | $4.17B | +19.7% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Lam Research Corporation shares, not any token. As of Jul 29, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q4 FY24ended Jun 30, 2024 | — | $0.78 | — | $3.87B | — | — |
| Q3 FY24ended Mar 31, 2024 | — | $0.73 | — | $3.79B | — | — |
| Q2 FY24ended Dec 24, 2023 | — | $0.72 | — | $3.76B | — | — |
| Q1 FY24ended Sep 24, 2023 | — | $0.67 | — | $3.48B | — | — |